S&P 500   4,593.00 (+1.20%)
DOW   35,237.55 (+1.90%)
QQQ   384.85 (+0.45%)
AAPL   166.28 (+2.74%)
MSFT   323.73 (+0.22%)
FB   315.65 (+2.87%)
GOOGL   2,851.48 (+0.40%)
AMZN   3,441.74 (+1.53%)
TSLA   992.16 (-2.25%)
NVDA   293.72 (-4.30%)
BABA   120.20 (+7.36%)
NIO   32.03 (-0.37%)
CGC   9.96 (-0.30%)
AMD   136.06 (-5.52%)
GE   96.72 (+4.26%)
MU   82.26 (+0.78%)
T   23.53 (+0.30%)
F   19.28 (+0.73%)
DIS   150.00 (+2.59%)
PFE   52.36 (-3.52%)
AMC   28.55 (-1.59%)
ACB   5.86 (+0.69%)
BA   205.92 (+3.74%)
S&P 500   4,593.00 (+1.20%)
DOW   35,237.55 (+1.90%)
QQQ   384.85 (+0.45%)
AAPL   166.28 (+2.74%)
MSFT   323.73 (+0.22%)
FB   315.65 (+2.87%)
GOOGL   2,851.48 (+0.40%)
AMZN   3,441.74 (+1.53%)
TSLA   992.16 (-2.25%)
NVDA   293.72 (-4.30%)
BABA   120.20 (+7.36%)
NIO   32.03 (-0.37%)
CGC   9.96 (-0.30%)
AMD   136.06 (-5.52%)
GE   96.72 (+4.26%)
MU   82.26 (+0.78%)
T   23.53 (+0.30%)
F   19.28 (+0.73%)
DIS   150.00 (+2.59%)
PFE   52.36 (-3.52%)
AMC   28.55 (-1.59%)
ACB   5.86 (+0.69%)
BA   205.92 (+3.74%)
S&P 500   4,593.00 (+1.20%)
DOW   35,237.55 (+1.90%)
QQQ   384.85 (+0.45%)
AAPL   166.28 (+2.74%)
MSFT   323.73 (+0.22%)
FB   315.65 (+2.87%)
GOOGL   2,851.48 (+0.40%)
AMZN   3,441.74 (+1.53%)
TSLA   992.16 (-2.25%)
NVDA   293.72 (-4.30%)
BABA   120.20 (+7.36%)
NIO   32.03 (-0.37%)
CGC   9.96 (-0.30%)
AMD   136.06 (-5.52%)
GE   96.72 (+4.26%)
MU   82.26 (+0.78%)
T   23.53 (+0.30%)
F   19.28 (+0.73%)
DIS   150.00 (+2.59%)
PFE   52.36 (-3.52%)
AMC   28.55 (-1.59%)
ACB   5.86 (+0.69%)
BA   205.92 (+3.74%)
S&P 500   4,593.00 (+1.20%)
DOW   35,237.55 (+1.90%)
QQQ   384.85 (+0.45%)
AAPL   166.28 (+2.74%)
MSFT   323.73 (+0.22%)
FB   315.65 (+2.87%)
GOOGL   2,851.48 (+0.40%)
AMZN   3,441.74 (+1.53%)
TSLA   992.16 (-2.25%)
NVDA   293.72 (-4.30%)
BABA   120.20 (+7.36%)
NIO   32.03 (-0.37%)
CGC   9.96 (-0.30%)
AMD   136.06 (-5.52%)
GE   96.72 (+4.26%)
MU   82.26 (+0.78%)
T   23.53 (+0.30%)
F   19.28 (+0.73%)
DIS   150.00 (+2.59%)
PFE   52.36 (-3.52%)
AMC   28.55 (-1.59%)
ACB   5.86 (+0.69%)
BA   205.92 (+3.74%)
NASDAQ:NVCN

Neovasc News Headlines

$0.65
0.00 (-0.25%)
(As of 12/6/2021 12:10 PM ET)
Add
Compare
Today's Range
$0.63
$0.65
50-Day Range
$0.65
$0.81
52-Week Range
$0.64
$2.60
Volume
7,280 shs
Average Volume
421,745 shs
Market Capitalization
$43.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.77

Media Mentions By Week



Neovasc Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NVCN
News Sentiment

0.12

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NVCN Articles
This Week

13

4

NVCN Articles
Average Week

Get Neovasc News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter.

Neovasc (NASDAQ:NVCN) News Headlines Today

SourceHeadline
finance.yahoo.com logoNeovasc Reducer™ System Receives National Reimbursement in France - Yahoo Finance
finance.yahoo.com - December 2 at 9:56 AM
streetinsider.com logoForm 6-K NEOVASC INC For: Dec 01 - StreetInsider.com
streetinsider.com - December 1 at 1:42 PM
globenewswire.com logoNeovasc to Participate in Sidoti December Virtual Microcap - GlobeNewswire
globenewswire.com - December 1 at 1:42 PM
finance.yahoo.com logoNeovasc to Participate in Sidoti December Virtual Microcap Conference
finance.yahoo.com - December 1 at 1:42 PM
MarketBeat logoNeovasc (NASDAQ:NVCN) Given Buy Rating at HC Wainwright
americanbankingnews.com - December 1 at 12:52 PM
MarketBeat logoNeovasc (NASDAQ:NVCN) Stock Passes Above 50-Day Moving Average of $0.74
americanbankingnews.com - December 1 at 2:52 AM
streetinsider.com logoForm 6-K NEOVASC INC For: Nov 30 - StreetInsider.com
streetinsider.com - November 30 at 7:41 PM
benzinga.com logoNeovasc Shares Spike Higher; Neovask Reducer System Receives National Reimbursement In France - Benzinga
benzinga.com - November 30 at 2:41 PM
streetinsider.com logoNeovasc (NVCN) Announces Neovasc Reducer System Receives National Reimbursement in France - StreetInsider.com
streetinsider.com - November 30 at 2:41 PM
globenewswire.com logoNeovasc Reducer™ System Receives National Reimbursement in - GlobeNewswire
globenewswire.com - November 30 at 2:41 PM
finance.yahoo.com logoNeovasc Reducer™ System Receives National Reimbursement in France
finance.yahoo.com - November 30 at 2:41 PM
finance.yahoo.com logoNeovasc Reducer(TM) System Receives National Reimbursement in France
finance.yahoo.com - November 30 at 2:41 PM
finance.yahoo.com logoThe National Institute for Health and Care Excellence of the United Kingdom Provides Positive Guidance for Neovasc Reducer System - Yahoo Finance
finance.yahoo.com - November 26 at 3:07 AM
seekingalpha.com logoNeovasc granted additional 180 days to regain Nasdaq bid price compliance - Seeking Alpha
seekingalpha.com - November 24 at 5:53 PM
finance.yahoo.com logoThe National Institute for Health and Care Excellence of The United Kingdom Provides Positive Guidance for Neovasc Reducer System
finance.yahoo.com - November 24 at 5:53 PM
finance.yahoo.com logoNeovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance
finance.yahoo.com - November 24 at 5:53 PM
globenewswire.com logoThe National Institute for Health and Care Excellence of The United Kingdom Provides Positive Guidance for Neovasc Reducer System - GlobeNewswire
globenewswire.com - November 24 at 12:53 PM
MarketBeat logoNeovasc Inc. (NASDAQ:NVCN) Short Interest Update
americanbankingnews.com - November 21 at 7:30 AM
seekingalpha.com logoNeovasc Inc. (NVCN) CEO Fred Colen on Q3 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 10 at 10:40 AM
finance.yahoo.com logoNeovasc (NVCN) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 9 at 11:21 PM
finance.yahoo.com logoNeovasc Announces Third Quarter 2021 Financial Results and Provides Corporate Update - Yahoo Finance
finance.yahoo.com - November 9 at 6:20 PM
finance.yahoo.com logoNeovasc Announces Third Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - November 9 at 6:20 PM
finance.yahoo.com logoNeovasc to Report Third Quarter 2021 Financial Results on November 9, 2021 - Yahoo Finance
finance.yahoo.com - November 1 at 2:05 PM
finance.yahoo.com logoNeovasc to Report Third Quarter 2021 Financial Results on November 9, 2021
finance.yahoo.com - November 1 at 2:05 PM
nasdaq.com logoNeovasc (NVCN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Nasdaq
nasdaq.com - October 29 at 10:25 AM
finance.yahoo.com logoNeovasc (NVCN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
finance.yahoo.com - October 28 at 7:18 PM
finance.yahoo.com logoNeovasc Reducer™ Featured in Polish Heart Journal - Yahoo Finance
finance.yahoo.com - October 22 at 1:06 AM
streetinsider.com logoNeovasc Reducer™ Featured in Polish Heart Journal - StreetInsider.com
streetinsider.com - October 21 at 3:05 PM
finance.yahoo.com logoNeovasc Reducer(TM) Featured in Polish Heart Journal - Yahoo Finance
finance.yahoo.com - October 21 at 10:04 AM
finance.yahoo.com logoNeovasc Reducer(TM) Featured in Polish Heart Journal
finance.yahoo.com - October 21 at 10:04 AM
finance.yahoo.com logoNeovasc Reducer™ Featured in Polish Heart Journal
finance.yahoo.com - October 21 at 10:04 AM
finance.yahoo.com logoMedtronic Warns On Percept PC Implantable Neurostimulators In Europe - Yahoo Finance
finance.yahoo.com - October 21 at 12:10 AM
finance.yahoo.com logoNKGen Biotech Announces Acceptance of SNK01 Abstract for Presentation at the 2021 Connective Tissue Oncology Society Annual Meeting - Yahoo Finance
finance.yahoo.com - October 20 at 8:57 AM
finance.yahoo.com logoPfizer/BioNTech COVID-19 vaccine highly protective in 12-18 age group - U.S. CDC study - Yahoo Finance
finance.yahoo.com - October 20 at 3:57 AM
finance.yahoo.com logoNeovasc Receives FDA Approval for COSIRA-II Clinical Trial - Yahoo Finance
finance.yahoo.com - October 19 at 10:56 PM
finance.yahoo.com logoWhy Energous Shares Are Soaring Today - Yahoo Finance
finance.yahoo.com - October 19 at 5:56 PM
finance.yahoo.com logoNeovasc Receives FDA Approval for COSIRA-II Clinical Trial
finance.yahoo.com - October 19 at 12:56 PM
finance.yahoo.com logoNeovasc REDUCER-I Study Published in EuroIntervention Journal - Yahoo Finance
finance.yahoo.com - September 28 at 11:09 PM
finance.yahoo.com logoNeovasc REDUCER-I Study Published in EuroIntervention Journal
finance.yahoo.com - September 28 at 11:09 PM
globenewswire.com logoNeovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference - GlobeNewswire
globenewswire.com - September 23 at 11:11 PM
finance.yahoo.com logoNeovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference - Yahoo Finance
finance.yahoo.com - September 23 at 1:10 PM
finance.yahoo.com logoNeovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference
finance.yahoo.com - September 23 at 1:10 PM
finance.yahoo.com logoWhy Are Neovasc Shares Moving Higher On Thursday? - Yahoo Finance
finance.yahoo.com - September 18 at 5:42 PM
benzinga.com logoWhy Are Neovasc Shares Moving Higher On Thursday? - Benzinga - Benzinga
benzinga.com - September 16 at 6:00 PM
finance.yahoo.com logoWhy Are Neovasc Shares Moving Higher On Thursday?
finance.yahoo.com - September 16 at 6:00 PM
finance.yahoo.com logoNeovasc Announces FDA Approval of COSIRA-II Clinical Trial - Yahoo Finance
finance.yahoo.com - September 16 at 1:00 PM
finance.yahoo.com logoNeovasc Announces FDA Approval of COSIRA-II Clinical Trial
finance.yahoo.com - September 16 at 1:00 PM
globenewswire.com logoNeovasc to Participate in HC Wainwright & Co. 23rd Annual Global Investment Conference - GlobeNewswire
globenewswire.com - August 30 at 8:51 PM
markets.businessinsider.com logoPeregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal - Markets Insider
markets.businessinsider.com - August 19 at 6:19 PM
finance.yahoo.com logoNeovasc Announces Submission of COSIRA-II Protocol Supplement to FDA - Yahoo Finance
finance.yahoo.com - August 17 at 5:47 PM
Get Neovasc News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.